Bulevirtide in the treatment of chronic hepatitis delta | DDDT - Dove Medical Press

Bulevirtide in the treatment of chronic hepatitis delta | DDDT - Dove Medical Press
The advent of new specific HDV antivirals, such as lonafarnib, will allow to explore the efficacy of combination therapy for hepatitis delta.
Introduction Hepatitis D virus (HDV) infection causes the most severe forms of both acute and chronic viral hepatitis. Approximately 12–15 million people are chronically infected with HDV worldwide.… [+41552 chars] Read More



Related Stories

See All